December 2021

WCHQ Committees Identify Initial Set of Measures to Evaluate Value

While the pandemic disrupted progress on the WCHQ Value Acceleration Initiative, which was launched in 2019, the Board asked staff to resume the work in 2021. WCHQ members are focused on further refining the definition of health care value to allow measurement and tracking of its improvement. Broadly, WCHQ’s definition of value is higher quality, more affordable care. The initial focus of this work is on individuals with diabetes, and the Value Acceleration Steering team was tasked with identifying interventions that increase value with a reasonable implementation threshold, to align with priorities for providers, purchasers and payers. The improvement strategies that group identified included integrating behavioral health and pharmacists into primary care, improving tobacco cessation rates, and reducing stress testing in individuals with stable disease after PCI.

Staff is developing a report that will include results for individual measures selected from a set identified by the Steering Team. Selected measures align with value improvement strategies endorsed by the WCHQ Board of Directors and will provide a baseline for tracking improvement over time. The Measurement Advisory Committee and Value Acceleration Advisory Group, chaired by Imran Andrabi, MD, President and CEO, ThedaCare will review the final iteration of the report prior to its dissemination in early 2022. The initial report will include member specific results and be blinded so members are only able to see their own performance in comparison to the rest of WCHQ.